Novel Heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2006253863 (hide)

Owner Addex Pharmaceuticals SA

Inventors Rocher, Jean-Philippe; Farina, Marco; Palombi, Giovanni; Le Poul, Emmanuel; Gagliardi, Stefania

Agent Spruson & Ferguson

Pub. Number AU-A-2006253863

PCT Pub. Number WO2006/129199

Priority 0510139.9 18.05.05 GB

Filing date 17 May 2006

Wipo publication date 7 December 2006

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4439 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/129199 Priority application(s): WO2006/129199

7 February 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Addex Pharmaceuticals SA, Application No. 2006253863, under INID (71), correct the applicant name to Addex Pharma SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006253864-System and method for managing water content in a fluid

2006253855-A method for optimized production of a recombinant form of tissue plasminogen activator